At American Gene Technologies we are very proud and fortunate to work with some of the best scientific and clinical advisors in their fields. As a team we continually push our research forward.
Our experienced executive team is committed to finding innovative solutions for patients living with infectious diseases, cancer, and monogenic disorders.
Founder and CEO
Jeff earned his BA degree in Economics from Harvard in 1981. He has more than 30 years of business and entrepreneurial experience including founder or executive positions at a variety of...
Andrew Miller, CPA
VP of Finance
Andrew has more than 20 years of experience in accounting, finance, strategy, raising capital, and corporate governance in both private companies and non-profit organizations.
Dr. Marcus A. Conant
Chief Medical Officer
Dr. Marcus Conant was one of the first physicians to diagnose and treat HIV/AIDS. Dr. Conant took the lead in forming the Kaposi’s Sarcoma Research & Education Foundation in 1982, which later became...
Senior Advisor to the CEO
Drew is a bold healthcare entrepreneur with rare expertise encompassing clinical medicine, information technology, and medical device. He is the founding CEO, Chief Medical Officer, and...
Dr. Jeff Boyle
Chief Science Officer
Dr. Boyle has over 25 years of research, development, and technical expertise with a deep understanding of biotechnology. Dr. Boyle has held multiple executive roles in the biotech and...
BOARD OF DIRECTORS
CEO and Founder
Jeff earned his BA degree in Economics from Harvard in 1981. He has more than 30 years of business and entrepreneurial experience including founder or executive positions at a variety of…
Jason T. Thompson
Jason combines legal experience and strategic vision in helping his clients structure, negotiate, and integrate corporate acquisitions. His training as a certified public accountant adds...
Aaron Galvin earned his BS and MS from the Massachusetts Institute of Technology (MIT), joining the MIT Lincoln Labs to pioneer innovations to radar as well as developing technologies for various classified…
Qi Tang has developed manufacturing and import/export businesses throughout China and the United States, and has invested several times throughout AGT’s growth.
Julia Brown has served on the board of directors of nine drug development companies with a focus on governance and compensation. She currently serves on the board and as a member of the…
Senior Advisor to the CEO
Tommy Thompson, former Secretary of the United States Department of Health and Human Services, worked fervently to modernize healthcare delivery as the former Governor of…
Dr. Robert R. Redfield
Special Advisor to the CEO
Dr. Redfield is well known for his decades of dedicated work in virology, immunology and clinical research. He has helped lead collaborative research into HIV/AIDS since the beginning of the epidemic...
DLA Piper provides AGT with corporate legal advice.
Foley & Lardner protects our innovative technologies and cures.
Ernst & Young serves as our independent public accountant.